Literature DB >> 20664830

Migraine is the most prevalent primary headache in individuals with temporomandibular disorders.

Ana L Franco1, Daniela A G Gonçalves, Sabrina M Castanharo, José G Speciali, Marcelo E Bigal, Cinara M Camparis.   

Abstract

AIMS: To assess the prevalence of primary headaches (HA) in adults with temporomandibular disorders (TMD) who were assessed in a specialty orofacial pain clinic, as well as in controls without TMD.
METHODS: The sample consisted of 158 individuals with TMD seen at a university-based specialty clinic, as well as 68 controls. The Research Diagnostic Criteria for TMD were used to diagnose the TMD patients. HAs were assessed using a structured interview and classified according to the Second Edition of the International Classification for Headache Disorders. Data were analyzed by chi-square tests with a significance level of 5% and odds ratio (OR) tests with a 95% confidence interval (CI).
RESULTS: HAs occurred in 45.6% of the control group (30.9% had migraine and 14.7% had tension-type headache [TTH]) and in 85.5% of individuals with TMD. Among individuals with TMD, migraine was the most prevalent primary HA (55.3%), followed by TTH (30.2%); 14.5% had no HA. In contrast to controls, the odds ratio (OR) for HA in those with TMD was 7.05 (95% confidence interval [CI] = 3.65-13.61; P = .000), for migraine, the OR was 2.76 (95% CI = 1.50-5.06; P = .001), and for TTH, the OR was 2.51 (95% CI = 1.18-5.35; P = .014). Myofascial pain/arthralgia was the most common TMD diagnosis (53.2%). The presence of HA or specific HAs was not associated with the time since the onset of TMD (P = .714). However, migraine frequency was positively associated with TMD pain severity (P = .000).
CONCLUSION: TMD was associated with increased primary HA prevalence rates. Migraine was the most common primary HA diagnosis in individuals with TMD.

Entities:  

Mesh:

Year:  2010        PMID: 20664830

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  23 in total

1.  Implementing gnathological and neuromuscular concepts in patients with chronic migraine.

Authors:  H Didier; C Marchetti; A Marchetti; D D'Amico; V Tullo; G Bussone; F Santoro
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders.

Authors:  Gülşen Kocaman; Neşe Kahraman; Banu Gürkan Köseoğlu; Başar Bilgiç; Zeliha Matur; Mustafa Ertaş; Yeşim Gülşen; Betül Baykan Baykal
Journal:  Noro Psikiyatr Ars       Date:  2018-07-06       Impact factor: 1.339

Review 3.  Orofacial pain and headache: a review and look at the commonalities.

Authors:  Steven D Bender
Journal:  Curr Pain Headache Rep       Date:  2014-03

Review 4.  How to investigate and treat: migraine in patients with temporomandibular disorders.

Authors:  Daniela A G Gonçalves; Cinara M Camparis; Ana Lucia Franco; Giovana Fernandes; José G Speciali; Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2012-08

Review 5.  Chronic Headache: a Review of Interventional Treatment Strategies in Headache Management.

Authors:  Ruchir Gupta; Kyle Fisher; Srinivas Pyati
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

6.  Evaluation of temporomandibular joint disorder in headache patients.

Authors:  Fergane Memmedova; Ufuk Emre; Osman Özgür Yalın; Onur Can Doğan
Journal:  Neurol Sci       Date:  2021-02-18       Impact factor: 3.307

7.  Diagnostic criteria for headache attributed to temporomandibular disorders.

Authors:  Eric Schiffman; Richard Ohrbach; Thomas List; Gary Anderson; Rigmor Jensen; Mike T John; Donald Nixdorf; Jean-Paul Goulet; Wenjun Kang; Ed Truelove; Al Clavel; James Fricton; John Look
Journal:  Cephalalgia       Date:  2012-07       Impact factor: 6.292

8.  Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches.

Authors:  Zdravko Lacković; Boris Filipović; Ivica Matak; Zsuzsanna Helyes
Journal:  Br J Pharmacol       Date:  2016-01       Impact factor: 8.739

9.  Preclinical studies investigating the neural mechanisms involved in the co-morbidity of migraine and temporomandibular disorders: the role of CGRP.

Authors:  Simon Akerman; Marcela Romero-Reyes
Journal:  Br J Pharmacol       Date:  2020-10-21       Impact factor: 8.739

Review 10.  Animal Models of Temporomandibular Disorder.

Authors:  Ting Xiang; Zhuo-Ying Tao; Li-Fan Liao; Shuang Wang; Dong-Yuan Cao
Journal:  J Pain Res       Date:  2021-05-26       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.